We evaluated the in vitro effects of IL-12, alone and in associIn this study, we investigated the effect of IL-12, alone and ation with IL-2 on MDS bone marrow and peripheral blood cells.
with excess of blasts (RAEB n = 14) and refractory anemia with excess of blasts in transformation (RAEB-t n = 1). Their clinical characteristics are summarized in Table 1 . For the purposes Introduction of this study, we decided to define RA + RARS as low-risk (LR) MDS and RAEB + RAEB-t as high-risk (HR) MDS. Patients with Severe peripheral blood cytopenia, together with bone mar-CMML were excluded from the study because of the small row hypercellularity and dysplasia are frequently the hallmark number who had been under our observation. of myelodysplastic syndromes (MDS).
1- 5 Although it has been established that these hematological disorders arise from the clonal expansion of the progeny of an aberrant pluripotential Cell preparation stem cell, [6] [7] [8] little it is known about their etiology and pathogenesis.
The PB and BM samples were collected in preservative-free Morphological involvement of the myeloid lineage is heparin. The mononuclear cells (MNC) were separated by always observed in MDS, whereas there is evidence of perigradient centrifugation using Ficoll Lymphoprep (Nicomed pheral lymphopenia and functional of B and T cell abnormaliPharma, Oslo, Norway) and then washed twice with phosties only in some cases. Attention has recently been directed phate-buffered saline. to the role of NK cells and immunoregulatory cytokines in the genesis of MDS. A number of studies have shown that peripheral blood natural killer-activity (NK-a) was decreased in MDS patients, [9] [10] [11] even though these observations do not BM and PB liquid cultures necessarily imply the clonal involvement of NK cells. 12, 13 IL-12 is a heterodimeric cytokine physiologically produced The PBMNC were suspended at a concentration of 1 × 10 6 by phagocytes, B lymphocytes and other antigen-presenting cells/ml in RPMI 1640 (Life Technologies, Gaithersburg, MD, cells (APC).
14-16 It has been shown to cause the proliferation USA) with 10% human AB serum (Flow ICN Biomedicals, of activated T and NK cells, to enhance the lytic activity of NK Costa Mesa, CA, USA), whereas the BMMNC were resuscells and to induce the production of antileukemic cytokines, pended at the same concentration in IMDM (Life particularly ␥-IFN. [16] [17] [18] [19] [20] In a previous study, we demonstrated Technologies) with 10% FCS (Hyclone Laboratories, Logan, that the defective bone marrow (BM) and peripheral blood UT, USA). RhIL-12 (Sigma-Aldrich, Milan, Italy) at a concen-(PB) NK-activity in MDS patients can be restored in vitro by tration of 0.1 ng/ml with or without RhIL-2 (Proleukin; Cetus the addition of another immunoregulatory cytokine, IL-2. 21 Corporation, Emeryville, CA, USA) 500 U/ml was added to the liquid cultures and then incubated at 37°C in 5% CO 2 for a week. The cells were then washed twice in PBS and the viability (always more than 90%) of the BM and PB cells was 
NK-activated cell assay Lymphocyte phenotype analysis
Before testing NK activity, we determined the percentage of The PB and BM mononuclear cells were labeled with antilymphocytes in the PBMNC and BMMNC in order to confirm CD3Fitc and CD56PE (Leu-4, Leu-3a+3b, Leu-2a, Leu-12; the effector/target ratio. . Minimum detectable concentratium (MDC) was 3 The spontaneous release value was always less than 10% of total radioactivity. pg/ml for ␣-TNF and GM-CSF, and 0.03 IU/ml for ␥-IFN.
Agar colony assay (CFU-GM)
respectively), although a significant increase was observed between the cultured controls and the IL-12-stimulated BM and PB cells. After incubation with IL-2, a significant (P Ͻ Clonogenic potential after incubation with IL-12 ± IL-2 was evaluated by means of agar colony assay (CFU-GM). 1 × 10 6 0.01) increase in NK-a was observed (average specific peripheral and bone marrow lysis was 51.7 and 36.9%, cells/ml in IMDM were cultured in 1 ml of a mixture containing 20% FCS, 3% agar, rhGM-CSF 200 U/ml (Genzyme, Camrespectively), which was only slightly lower than that seen in the IL-2-stimulated normal controls. The association of the bridge, MA, USA) and IL-3 100 U/ml (Genzyme). The plates were incubated in humidified air with 5% CO 2 at 37°C for 2 two cytokines led to an increase in NK-a that fell between the values reached by each of them alone (average percent speweeks. The aggregates containing Ͼ50 cells were scored as colonies, whereas those containing Ͻ50 cells were scored as cific peripheral and bone marrow lysis was 40.2 and 22.7%, respectively). No statistically significant differences were clusters. All of the cultures were set up in triplicate.
observed between LR and HR groups (Figure 2a and b) .
Statistical analysis
The Wilcoxon-matched-pairs-signed-rank's test was used to
Lymphocyte immunophenotype evaluate the within-group differences, and the Mann-Whitney test for the differences between groups. A P value of Ͻ0.05 was considered to be statistically significant.
No difference was observed in the immunophenotypes of the MDS samples with and without the addition of IL-12 after 7 days of culture. As already observed, 16 Figure 1 . We each of them alone. No statistically significant differences can assume that IL-12 0.1 U/ml for 1 week better stimulates were observed between LR and HR groups. NK-a, although not significantly so in comparison with the basal value. As far as IL-2, GM-CSF and IL-3 are concerned, we used the same dosages as those used in our previous study. 21 Once again, we also evaluated the sequential stimulus IL-2 → IL-12 (IL-2 was added at t = 0, IL-12 after 24 h), but we did not observe any increase in NK-a with respect to the sample treated with a simultaneous stimulus (data not shown).
NK activity
As already observed in a previous study, 21 baseline peripheral and bone marrow NK-a in the MDS patients was lower than in the normal subjects: the average specific lysis in peripheral blood was 14.6% in MDS patients and 38.6% in normal controls (P Ͻ 0.01), whereas bone marrow NK-a was 5.3% in MDS patients and 7.2% in donors (NS). IL-12 stimulation did not induce any increase in NK-a in peripheral and bone marrow MDS cells with respect to pre-cultured controls (average specific peripheral and bone marrow lysis was 13.3 and 8%,
Figure 2
Pre-and post-IL-12 and/or IL-2 stimulation on PB (a) and BM (b) NK-activity (± s.e.) in normals and MDS patients. Percentage of specific lysis of K562 cells at an E:T ratio of 50:1 for PB and of Figure 1 Effect of IL-12 on NK-a of normal PB cells at time 0 and after 1, 2, 3 and 7 days.
25:1 for BM. *P Ͻ 0.05; **P Ͻ 0.01. 
Clonogenic assay
The 7-days preincubation with IL-12 in the liquid culture did but the number of clusters decreased (although not significantly) after the addition of the cytokines to the medium with respect to the untreated control (IL-2 + 12Ͼ12Ͼ2) (Figure case, to a lesser extent than optimal doses of IL-2. 14 It is also known that IL-12 releases into the culture medium large 5). Unlike in our previous study, 16 we did not observe any significant increase in the number of CFU-GM after incuamounts of ␥-IFN, [16] [17] [18] [19] [20] a cytokine with potent antiproliferative activity. These characteristics, together with the fact that NKbation with IL-2. a is reduced in MDS patients, prompted us to evaluate the in vitro effects of IL-12 on the bone marrow and peripheral blood cells of such patients.
Discussion
In our in vitro system, IL-12 induced a modest but nonsignificant increase in NK-a in both normal and myelodysplasIt is well known that IL-12 is capable of stimulating the cytotoxic activity of both T and NK cells, although, in the latter tic cells in comparison with basal values. In contrast, the use kines in amounts similar to those secreted by normal control cells. In our in vitro system, we did not observe any increase in the number of CFU-GM prepared after 7 days of incubation with IL-2, IL-12 and IL-2 + 12 in comparison with control values. The non-significant increase in clonogenic activity after the addition of IL-2 appears to contradict our previous results and may be related to the longer time of incubation: the amount of inhibitory cytokines released in the supernatant after 7 days was much higher than that observed after the 24-and 72-h incubation periods used in our previous study. Furthermore, we did not observe any increase in the number of immature myeloid cells after incubation with IL-2, IL-12 and IL-2 + 12 when the centrifuged cells were morphologically analyzed (data not shown). Finally, we observed a progress- of clusters after incubation with IL-2, IL-12 and IL-2 + 12 in comparison with control samples (respectively: 13.9 clusters/ml, 11 clusters/ml, 10.6 clusters/ml and 14.8 clusters/ml). The colony/cluster ratio was 2.5 in the controls, of IL-2 led to a marked increase in BM and PB cell NK-a in the MDS patients that was only slightly lower than that which increased to 2.8 after stimulation with IL-2, and to 2.7 after stimulation with IL-12. After double stimulation (IL-2 + observed in normal subjects (average specific lysis of 36.9 vs 44.8% and 51.7 vs 61.4%, respectively). Unlike Ogata et al,
22
IL-12), the ratio was 2.4 which may be explained by the inhibitory action of ␥-IFN on normal myelopoiesis, 29 as its levwe did not observe any synergistic activity between IL-2 and IL-12 in the enhancement of NK-a in either normal or MDS els were considerably higher in the supernatant. We can therefore conclude that neither IL-2 nor IL-12 stimulate the subjects; however, this may be due to our different IL-2 and IL-12 doses and culture times. Gately et al 23 observed that the proliferation of the leukemic component. It is known that IL-12, together with other cytokines such as IL-3 and SCF, [30] [31] [32] association of IL-12 and IL-2 in culture for 4 days may lead to increases or decreases in LAK activity, depending on the belongs to the group of early-acting cytokines that acts on hemopoietic progenitors. Further studies are necessary to quantity of IL-12. Furthermore, other studies 24 have shown that the association of IL-12 + IL-2 in culture for 18 h increases evaluate whether IL-12 and other early-acting cytokines may stimulate clonal and non-clonal stem cells in MDS. cytolytic activity only marginally in comparison with optimal doses of IL-2.
Our study shows that IL-12 does not induce a significant increase in NK activity or in the number of CD3 −
/CD56
+ cells We did not observe any increase in the number of CD3 − /CD56 + cells after IL-12 stimulation in either the MDS in MDS subjects, but it is particularly active in the release of antitumoral cytokines, especially ␥-IFN. This last finding patients or controls, which was not the case after stimulation with IL-2; as for NK-a, the increase after double stimulation makes it possible to hypothesize the use of IL-12 particularly in clinical studies involving patients with a high bone marrow with IL-12 + IL-2 fell between the values obtained using the two cytokines individually. This result also confirms the data blastic component. 33 In addition to having a potent antitumoral effect, 34 ␥-IFN may also play a protective role against intrapublished in the literature concerning normal control subjects in whom IL-2 induces CD3 − /CD56 + proliferation, whereas ILcellular pathogen infections [35] [36] [37] as a result of the known ␥-IFN-driven macrophage activation. Finally, IL-12 may play a 12 appears to have no effect on the proliferation of the nonactivated NK compartment. Furthermore, although IL-12 is further and important role in resistance to infection by increasing the cell-mediated response that depends on the Th1 cell capable of inducing activated T cell proliferation, it mainly inhibits the IL-2-induced proliferation of NK cells. 25 This effect development that is regulated by IL-12 itself. 23, 38 The double stimulus of IL-2 + IL-12 may potentiate not only the release of is at least partially indirect, and depends on the ␣-TNF production induced by IL-12, as can be seen by the fact that antiantileukemic cytokines but also the release of GM-CSF, which could enhance the proliferation of residual normal hemopo-TNF antibodies are capable of restoring approximately 70% of the IL-2-induced proliferation. 23, [25] [26] [27] ietic progenitors. The potential importance of these possible effects would justify further and more specific investigations. However, in our in vitro system, IL-12 led to a dramatic increase in ␥-INF and ␣-TNF in the cell culture medium of both normal subjects and MDS patients. In particular, in the MDS samples, IL-12 proved to be a more potent inducer of
